Literature DB >> 22327962

Quantitative T 2* assessment of acute and chronic myocardial ischemia/reperfusion injury in mice.

Eissa N E Aguor1, Fatih Arslan, Cees W A van de Kolk, Marcel G J Nederhoff, Pieter A Doevendans, Cees J A van Echteld, Gerard Pasterkamp, Gustav J Strijkers.   

Abstract

OBJECT: Imaging of myocardial infarct composition is essential to assess efficacy of emerging therapeutics. T (2) (*) mapping has the potential to image myocardial hemorrhage and fibrosis by virtue of its short T (2) (*) . We aimed to quantify T (2) (*) in acute and chronic myocardial ischemia/reperfusion (I/R) injury in mice.
MATERIALS AND METHODS: I/R-injury was induced in C57BL/6 mice (n = 9). Sham-operated mice (n = 8) served as controls. MRI was performed at baseline, and 1, 7 and 28 days after surgery. MRI at 9.4 T consisted of Cine, T (2) (*) mapping and late-gadolinium-enhancement (LGE). Mice (n = 6) were histologically assessed for hemorrhage and collagen in the fibrotic scar.
RESULTS: Baseline T (2) (*) values were 17.1 ± 2.0 ms. At day 1, LGE displayed a homogeneous infarct enhancement. T (2) (*) in infarct (12.0 ± 1.1 ms) and remote myocardium (13.9 ± 0.8 ms) was lower than at baseline. On days 7 and 28, LGE was heterogeneous. T (2) (*) in the infarct decreased to 7.9 ± 0.7 and 6.4 ± 0.7 ms, whereas T (2) (*) values in the remote myocardium were 14.2 ± 1.1 and 15.6 ± 1.0 ms. Histology revealed deposition of iron and collagen in parallel with decreased T (2) (*) .
CONCLUSION: T (2) (*) values are dynamic during infarct development and decrease significantly during scar maturation. In the acute phase, T (2) (*) values in infarcted myocardium differ significantly from those in the chronic phase. T (2) (*) mapping was able to confirm the presence of a chronic infarction in cases where LGE was inconclusive. Hence, T (2) (*) may be used to discriminate between acute and chronic infarctions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327962      PMCID: PMC3458196          DOI: 10.1007/s10334-012-0304-0

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  45 in total

1.  Remote myocardial dysfunction after acute anterior myocardial infarction: impact of left ventricular shape on regional function: a magnetic resonance myocardial tagging study.

Authors:  J Bogaert; H Bosmans; A Maes; P Suetens; G Marchal; F E Rademakers
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

2.  Mouse myocardial first-pass perfusion MR imaging.

Authors:  Bram F Coolen; Rik P M Moonen; Leonie E M Paulis; Tessa Geelen; Klaas Nicolay; Gustav J Strijkers
Journal:  Magn Reson Med       Date:  2010-12       Impact factor: 4.668

3.  Slow clearance gadolinium-based extracellular and intravascular contrast media for three-dimensional MR angiography.

Authors:  J Bremerich; J M Colet; G B Giovenzana; S Aime; K Scheffler; S Laurent; G Bongartz; R N Muller
Journal:  J Magn Reson Imaging       Date:  2001-04       Impact factor: 4.813

4.  Assessment of ventricular function with cardiovascular magnetic resonance.

Authors:  Thomas F Walsh; W Gregory Hundley
Journal:  Magn Reson Imaging Clin N Am       Date:  2007-11       Impact factor: 2.266

Review 5.  T2-weighted magnetic resonance imaging to assess myocardial oedema in ischaemic heart disease.

Authors:  N C Edwards; H Routledge; R P Steeds
Journal:  Heart       Date:  2009-05-15       Impact factor: 5.994

6.  Contrast-enhanced magnetic resonance imaging reveals early decrease of transmural extent of reperfused acute myocardial infarction.

Authors:  Constanze Merten; Henning Steen; Christian Kulke; Evangelos Giannitsis; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

7.  Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.

Authors:  Benedetta Leonardi; Renee Margossian; Steven D Colan; Andrew J Powell
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

8.  Regional three-dimensional geometry and function of left ventricles with fibrous aneurysms. A cine-computed tomography study.

Authors:  J Lessick; S Sideman; H Azhari; M Marcus; E Grenadier; R Beyar
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

9.  Regional differences in function within noninfarcted myocardium during left ventricular remodeling.

Authors:  C M Kramer; J A Lima; N Reichek; V A Ferrari; M R Llaneras; L C Palmon; I T Yeh; B Tallant; L Axel
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

Review 10.  Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability.

Authors:  Antti Saraste; Stephan Nekolla; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2007-12-21       Impact factor: 5.952

View more
  6 in total

1.  Assessment of Myocardial Fibrosis in Mice Using a T2*-Weighted 3D Radial Magnetic Resonance Imaging Sequence.

Authors:  Bastiaan J van Nierop; Noortje A M Bax; Jules L Nelissen; Fatih Arslan; Abdallah G Motaal; Larry de Graaf; Jaco J M Zwanenburg; Peter R Luijten; Klaas Nicolay; Gustav J Strijkers
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

2.  Cardiac-respiratory self-gated cine ultra-short echo time (UTE) cardiovascular magnetic resonance for assessment of functional cardiac parameters at high magnetic fields.

Authors:  Verena Hoerr; Nina Nagelmann; Arno Nauerth; Michael T Kuhlmann; Jörg Stypmann; Cornelius Faber
Journal:  J Cardiovasc Magn Reson       Date:  2013-07-04       Impact factor: 5.364

3.  Cardiovascular magnetic resonance T2* mapping for structural alterations in hypertrophic cardiomyopathy.

Authors:  Mareike Gastl; Alexander Gotschy; Jochen von Spiczak; Malgorzata Polacin; Florian Bönner; Christiane Gruner; Malte Kelm; Frank Ruschitzka; Hatem Alkadhi; Sebastian Kozerke; Robert Manka
Journal:  Eur J Radiol Open       Date:  2019-02-04

4.  Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI.

Authors:  Gustav J Strijkers; Ericky C A Araujo; Noura Azzabou; David Bendahan; Andrew Blamire; Jedrek Burakiewicz; Pierre G Carlier; Bruce Damon; Xeni Deligianni; Martijn Froeling; Arend Heerschap; Kieren G Hollingsworth; Melissa T Hooijmans; Dimitrios C Karampinos; George Loudos; Guillaume Madelin; Benjamin Marty; Armin M Nagel; Aart J Nederveen; Jules L Nelissen; Francesco Santini; Olivier Scheidegger; Fritz Schick; Christopher Sinclair; Ralph Sinkus; Paulo L de Sousa; Volker Straub; Glenn Walter; Hermien E Kan
Journal:  J Neuromuscul Dis       Date:  2019

5.  Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy.

Authors:  Mareike Gastl; Christiane Gruner; Karin Labucay; Alexander Gotschy; Jochen Von Spiczak; Malgorzata Polacin; Florian Boenner; Malte Kelm; Frank Ruschitzka; Hatem Alkadhi; Sebastian Kozerke; Robert Manka
Journal:  Open Heart       Date:  2020-03-15

6.  IL-10 provides cardioprotection in diabetic myocardial infarction via upregulation of Heme clearance pathways.

Authors:  Rajesh Gupta; Lijun Liu; Xiaolu Zhang; Xiaoming Fan; Prasanna Krishnamurthy; Suresh Verma; Jörn Tongers; Sol Misener; Nikita Ashcherkin; Hongliu Sun; Jiang Tian; Raj Kishore
Journal:  JCI Insight       Date:  2020-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.